-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on BrightSpring Health, Raises Price Target to $85

Benzinga·07/08/2026 18:18:17
Listen to the news
UBS analyst A.J. Rice maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $63 to $85.